Robert Mauch, AmerisourceBergen (ABC)’s insider Unloaded 1,000 Shares; Lattice Semiconductor (LSCC) Has 0.95 Sentiment

AmerisourceBergen Corporation (NYSE:ABC) Logo

Sentiment for Lattice Semiconductor Corp (LSCC)

Lattice Semiconductor Corp (LSCC) investors sentiment decreased to 0.95 in Q4 2017. It’s down -0.05, from 1 in 2017Q3. The ratio has dropped, as 59 institutional investors increased and started new stock positions, while 62 sold and trimmed stakes in Lattice Semiconductor Corp. The institutional investors in our database reported: 98.81 million shares, up from 98.38 million shares in 2017Q3. Also, the number of institutional investors holding Lattice Semiconductor Corp in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 21 Reduced: 41 Increased: 32 New Position: 27.

The Executive Vice President of Amerisourcebergen Corp, Robert Mauch, has just sold – 1,000 shares of the company he’s managing and supervising – coming to an aggregate trade of $93,280 U.S. Dollars (this based on share price of $93.3). Robert is trying to quietly decrease his company’s share, same as he did in the last month. He unloaded another 1,000 shares worth $90,000 USD. Robert Mauch currently owns 12,123 shares or 0.01% of the company’s market cap.

Analysts await AmerisourceBergen Corporation (NYSE:ABC) to report earnings on May, 2 before the open. They expect $1.80 earnings per share, up 1.69% or $0.03 from last year’s $1.77 per share. ABC’s profit will be $395.39M for 12.39 P/E if the $1.80 EPS becomes a reality. After $1.55 actual earnings per share reported by AmerisourceBergen Corporation for the previous quarter, Wall Street now forecasts 16.13% EPS growth.

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. The company has market cap of $19.59 billion. The Company’s Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It has a 20.18 P/E ratio. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers.

Among 20 analysts covering AmerisourceBergen (NYSE:ABC), 12 have Buy rating, 0 Sell and 8 Hold. Therefore 60% are positive. AmerisourceBergen has $130 highest and $9 lowest target. $97.47’s average target is 9.27% above currents $89.2 stock price. AmerisourceBergen had 74 analyst reports since July 27, 2015 according to SRatingsIntel. The stock has “Mkt Perform” rating by Leerink Swann on Friday, November 4. Needham maintained the shares of ABC in report on Friday, September 8 with “Buy” rating. TheStreet upgraded AmerisourceBergen Corporation (NYSE:ABC) on Monday, July 27 to “Buy” rating. The firm earned “Hold” rating on Tuesday, February 6 by Mizuho. The company was upgraded on Thursday, November 10 by Morgan Stanley. Robert W. Baird maintained AmerisourceBergen Corporation (NYSE:ABC) on Wednesday, January 17 with “Buy” rating. The firm has “Neutral” rating by Mizuho given on Tuesday, January 3. The firm earned “Hold” rating on Wednesday, January 24 by Mizuho. Leerink Swann maintained it with “Buy” rating and $9000 target in Monday, August 7 report. The firm has “Buy” rating by Needham given on Tuesday, October 24.

The stock decreased 1.52% or $1.38 during the last trading session, reaching $89.2. About 1.67 million shares traded. AmerisourceBergen Corporation (NYSE:ABC) has declined 3.97% since May 1, 2017 and is downtrending. It has underperformed by 15.52% the S&P500.

Analysts await Lattice Semiconductor Corporation (NASDAQ:LSCC) to report earnings on May, 8. They expect $0.03 EPS, 0.00% or $0.00 from last year’s $0.03 per share. LSCC’s profit will be $3.73 million for 45.33 P/E if the $0.03 EPS becomes a reality. After $-0.02 actual EPS reported by Lattice Semiconductor Corporation for the previous quarter, Wall Street now forecasts -250.00% EPS growth.

Simcoe Capital Management Llc holds 1.34% of its portfolio in Lattice Semiconductor Corporation for 670,990 shares. Nwq Investment Management Company Llc owns 7.95 million shares or 0.6% of their US portfolio. Moreover, Menta Capital Llc has 0.44% invested in the company for 393,304 shares. The Texas-based Hilltop Holdings Inc. has invested 0.39% in the stock. Hutchin Hill Capital Lp, a New York-based fund reported 184,900 shares.

Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor devices in Asia, Europe, and the Americas. The company has market cap of $675.71 million. The firm offers programmable logic devices that consist of five product family lines, such as the ECP, MachXO, iCE40, CrossLink, and programmable mixed signal devices. It currently has negative earnings. It also provides video connectivity application specific standard products, including port processors, port controllers, video processors, transmitters, receivers, bridges, and converters for use in mobile phones, HD TVs, home theater systems, HDMI cable extenders, automotive infotainment, PCs, accessories, projectors, and monitors.

Lattice Semiconductor Corporation (NASDAQ:LSCC) Institutional Positions Chart